David Templeton
Chief Tech/Sci/R&D Officer at N4 PHARMA PLC
Net worth: - $ as of 30/03/2024
Profile
David Templeton is currently the Executive Director & Technical Director at N4 Pharma Plc since 2019.
Previously, he worked as the Director-Clinical Pharmacology at Eisai Ltd.
(United Kingdom) from 2007 to 2010 and as the Head-Non Clinical Development at Celltech Ltd.
from 2003 to 2004.
He also held the position of Head-Biometrics at Merck Generics Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
N4 PHARMA PLC
-.--% | 30/12/2022 | 0 ( -.--% ) | - $ | 30/03/2024 |
David Templeton active positions
| Companies | Position | Start |
|---|---|---|
| N4 PHARMA PLC | Chief Tech/Sci/R&D Officer | 20/05/2019 |
Former positions of David Templeton
| Companies | Position | End |
|---|---|---|
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Corporate Officer/Principal | 31/12/2009 |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | 31/12/2003 |
Merck Generics Ltd.
 Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Health Technology |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
| N4 Pharma Plc | |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Health Technology |
- Stock Market
- Insiders
- David Templeton
